Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results
Date:11/9/2009

pipeline, including KRX-0401 and Zerenex; or the effect on our stock value of the other risk factors identified from time to time in our reports filed with the Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. We do not intend to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. This press release and prior releases are available at http://www.keryx.com. The information in our website is not incorporated by reference into this press release and is included as an inactive textual reference only.

    KERYX CONTACT:
    Lauren Fischer
    Director - Investor Relations
    Keryx Biopharmaceuticals, Inc.
    Tel: 212.531.5965
    E-mail: lfischer@keryx.com
                             Keryx Biopharmaceuticals, Inc.
                         Selected Consolidated Financial Data
                  (In Thousands, Except Share and Per Share Amounts)

                       Statements of Operations Information:

                                      Three Months Ended     Nine Months Ended
                                          September 30,        September 30,
                                          (unaudited)           (unaudited)
                                       2009        2008       2009       2008
                                       ----        ----       ----       ----
    REVENUE:
    License revenue                  $   --     $   327    $21,616     $  853
    Service revenue                      --          41          3        103
    Other revenue                     3,500          --      3,575         --
                                 --------------------------------------------
    TOTAL REVENUE                     3,500         368    
'/>"/>
SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST
2. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
3. Keryx Reports Results of Open Label Extension Study Examining Long-Term Use of Zerenex, an Iron-Based Phosphate Binder, for the Treatment of Hyperphosphatemia
4. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
5. Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
6. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
7. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
8. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
9. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
10. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
11. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4 mars 2015  RedHill ... ou la « Société »), une société ... les spécialités pharmaceutiques administrés par ... clinique avancé pour les maladies ... les cancers gastro-intestinaux, a annoncé ...
(Date:3/4/2015)... Company plc (NYSE: PRGO ; TASE) today announced ... will present at the 2015 Barclays Global Healthcare Conference ... Loews Miami Beach Hotel in Miami, FL. ... http://perrigo.investorroom.com/events-webcasts . From its beginnings as a packager ... in Ireland , has grown to become ...
(Date:3/4/2015)... NEWARK, N.J. , March 4, 2015 /PRNewswire/ ... biopharmaceutical company developing innovative medicines for serious women,s ... 1 clinical program demonstrating that its lead product ... had predictable pharmacokinetics (PK), and that contraceptive efficacy ... by SYM-1219 administration. These results will ...
Breaking Medicine Technology:RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 2RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 3RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 4RedHill Biopharma présentera à l'événement en ligne sur VirtualInvestorConferences.com le 5 mars 2015 5Perrigo Company To Present At The 2015 Barclays Global Healthcare Conference 2Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 2Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 3Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 4Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 5
... resistance ... in small cell lung cancer -, SOUTH SAN FRANCISCO, Calif., ... company focused,on oncology, today announced that preliminary data from a Phase ... tumors will be,presented at the 2008 American Association for Cancer Research ...
... BRUSSELS and NEWARK, New Jersey, March 19 ... the UMDNJ-University Hospital,(UH) in Newark, New Jersey from ... interventions to improve outpatient care and,access for people ... teaching hospital provides care for a low-income, minority,population ...
Cached Medicine Technology:Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting 2Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting 3UMDNJ-University Hospital in Newark to Tailor Diabetes Interventions for Low-Income and Minority Groups With Grant From the International Diabetes Federation 2UMDNJ-University Hospital in Newark to Tailor Diabetes Interventions for Low-Income and Minority Groups With Grant From the International Diabetes Federation 3UMDNJ-University Hospital in Newark to Tailor Diabetes Interventions for Low-Income and Minority Groups With Grant From the International Diabetes Federation 4
(Date:3/4/2015)... 04, 2015 Vancouver chiropractic clinic, ... two awards in the prestigious Vancouver Courier “Stars ... 27, 2015. The company secured third place in ... the “Best Registered Massage Therapist” category. , ... in Canada, The Vancouver Courier is a semiweekly ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 As ... Endometriosis can be a painful condition in ... spreading outside of the uterus leading to very unpleasant ... families. Endometriosis can have a terrible effect on women’s ... is also the most common cause of infertility in ...
(Date:3/4/2015)... The report covers spices market upstream ... industry development trend and proposals. The report provides ... definitions, applications and industry chain structure. Global market ... with a focus on history, developments, trends and ... the international and Chinese situation is also offered. ...
(Date:3/4/2015)... 2015 Plungerhead has partnered ... members during and after their service to the country. ... awareness through advertising, social media and several national special ... organization through a special retail promotion of Plungerhead Lodi ... through May 2015. , “There is a vital ...
(Date:3/4/2015)... New York, NY (PRWEB) March 04, 2015 ... hit talk show “The Real” graces the cover of the ... by encouraging readers to choose organic when shopping for clothes ... medalist Nastia Liukin opens up about her commitment to an ... given me more energy, not only in gymnastics, but also ...
Breaking Medicine News(10 mins):Health News:Backs in Action Receives Two Awards in The Vancouver Courier Readers’ Choice Awards 2015 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 3Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 3Health News:Plungerhead Partners with the Boot Campaign to Benefit US Military Community 2Health News:Plungerhead Partners with the Boot Campaign to Benefit US Military Community 3
... Neuisys Imaging System,Solutions, LLC announced today that the U.S. ... the NeuViz 16 Multi-Slice Computed,Tomography (CT) System. The NeuViz ... venture between Royal Philips Electronics of the Netherlands,and Neusoft ... NeuViz 16 is a state-of-the-art CT system that provides ...
... hypertension during pregnancy, Marshal D. Lindheimer, MD, professor emeritus ... Medicine and in the Committee on Clinical Pharmacology and ... 2009 Joseph Bolivar DeLee Humanitarian Award from the Board ... University of Chicago Medical Center. , The ...
... Accounting Related to Two Transactions , PHOENIX, Feb. 23 ... in stabilized rice bran (SRB) nutrient research and technology, ... recommendations of the Audit Committee of its Board of ... fiscal year ended December 31, 2007. This includes the ...
... 23 HealthyPlace.com , which provides the most extensive ... the internet, unveils several important new features for those ... features HealthyPlace Mediminder , a free medication reminder ... them to take their medication or refill their prescription. ...
... Fiber Bring Great Taste and Digestive Health Benefits to ... Company, Inc., announced today that it will expand the ... probiotic portfolio. Both cultured fresh dairy products, Activia Dairy ... the same scientifically proven benefits of all Activia products, ...
... say yes, but American experts aren,t so sure , , ... Taiwan links aggression in teens to heavy Internet use, ... , The research, based on questionnaires about Internet ... percent of the boys and 13 percent of the girls ...
Cached Medicine News:Health News:Neuisys Announces FDA Clearance of NeuViz 16 Multi-Slice CT System 2Health News:2009 DeLee Humanitarian Award goes to Marshall Lindheimer, M.D., of the University of Chicago 2Health News:2009 DeLee Humanitarian Award goes to Marshall Lindheimer, M.D., of the University of Chicago 3Health News:NutraCea to Restate Financial Statements for 2007 and 2008 2Health News:NutraCea to Restate Financial Statements for 2007 and 2008 3Health News:NutraCea to Restate Financial Statements for 2007 and 2008 4Health News:NutraCea to Restate Financial Statements for 2007 and 2008 5Health News:HealthyPlace.com, the Largest Consumer Mental Health Site, Re-Launches With Important New Features for the More Than 30 Million People Who Suffer from Anxiety, Depression and Bipolar Disorder 2Health News:HealthyPlace.com, the Largest Consumer Mental Health Site, Re-Launches With Important New Features for the More Than 30 Million People Who Suffer from Anxiety, Depression and Bipolar Disorder 3Health News:Dannon(TM) Expands Probiotic Portfolio with New Activia(TM) Extensions 2Health News:Dannon(TM) Expands Probiotic Portfolio with New Activia(TM) Extensions 3Health News:Are Internet-Addicted Kids More Violent? 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: